Patrick J. Geraghty, MD
Back To Last Session: Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Wednesday, November 20, 2019 |
Presenter
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
Understanding US FDA IDEs (Investigative Device Exemptions) Trials For Evaluating Lower Extremity Endo Devices – Especially BTK Devices: What These Will Tell Us (About Patency) And What They Won’t Tell Us (About Amputation Free Survival)
6:40 AM - 6:45 AM
|
Presenter
Eluvia (Boston Scientific) Is The Only Polymer Based Paclitaxel DES Technology, And It Is Now Being Studied For BTK Lesions In The SAVAL RCT
8:28 AM - 8:33 AM
|
Presenter
Results Of A RCT Show The Lutonix DCB (Becton Dickinson/Bard) To Be Better Than POBA For BTK Occlusive Lesions
11:19 AM - 11:24 AM
|
Thursday, November 21, 2019 |
Presenter
How Well Does The Tack Endovascular System Work With BTK Balloon Angioplasty: TOBA II BTK-Pivotal Trial Results For A BTK Tack Implant
2:34 PM - 2:39 PM
|
previous | next |